Mycophenolate Mofetil 500 mg/1

Mycophenolate Mofetil 500 mg tablets are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Hikma Pharmaceuticals USA Inc. and is available in a 500-tablet bottle.

Mycophenolate Mofetil is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. This medication is often prescribed in combination with other immunosuppressants to enhance effectiveness. Patients should consult their healthcare provider to understand the specific uses of Mycophenolate Mofetil for their condition.

Common effects of Mycophenolate Mofetil may include nausea, vomiting, diarrhea, and abdominal pain. Some users might experience fatigue, headache, or infections due to the medication's impact on the immune system. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Mycophenolate Mofetil should be handled with care, especially by pregnant women or those planning to become pregnant, as it can cause birth defects. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should avoid activities that require alertness until they know how the medication affects them.

Mycophenolate Mofetil may interact with other medications, including antacids, cholesterol-lowering drugs, and certain antibiotics. It is crucial to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol consumption should be minimized, as it can exacerbate the side effects of this medication.